Mar 10, 2021 / 01:00PM GMT
Luke England Sergott - Barclays Bank PLC, Research Division - Research Analyst
And that's it, I think we're live. So good morning, everybody. Luke Sergott from Barclays, cover Life Sciences, Tools and Diagnostics here. This is my great pleasure to welcome Brendan Brennan and Jonathan Curtain from ICON.
If you guys -- I think you guys want to do kind of a little quick introduction, and then we'll dive right into some questions.
Brendan Brennan - ICON Public Limited Company - CFO
Sure. It's great to be at least on the conference with you guys, again, virtually this time. Unfortunately, my view out the window of a very, very dull, wet. So doesn't really compare it to the usual Miami Beach scape, but we're considering putting a picture over the window to make ourselves feel a little bit better.
Obviously, it's been a busy couple of weeks, and I'm sure we'll get into some nice Q&A with Luke shortly. But we're obviously excited about the recent developments that have happened here at ICON in terms of our acquisition of PRA. We think it really is
ICON PLC at Barclays Global Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot